Role of mitochondrial permeability transition in the immature brain following intrauterine ischemia

Journal of Nippon Medical School

Volumn 74, Issue 3, 2007, Pages 190-201

  Nakai, Akihito ^a,b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NIPPON MEDICAL SCHOOL TAMA NAGAYAMA HOSPITAL   (Japan)

Author keywords

Brain; Fetal; Ischemia; Mitochondria

Indexed keywords

CYCLOSPORIN A;

BIOENERGY; BRAIN DAMAGE; BRAIN ISCHEMIA; CLINICAL FEATURE; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON MICROSCOPY; ENERGY METABOLISM; MITOCHONDRIAL PERMEABILITY; NONHUMAN; PROPHYLAXIS; RESPIRATORY FUNCTION; REVIEW; SWELLING; ULTRASTRUCTURE;

ANIMALS; FETAL HYPOXIA; HYPOXIA-ISCHEMIA, BRAIN; MITOCHONDRIA; PERMEABILITY; RATS;

EID: 34347350012     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.74.190     Document Type: Review

References (88)

1. Duffy TE, Kohle SJ, Vannucci RC: Carbohydrate and energy metabolism in perinatal rat brain: relation to survival in anoxia. J Neurochem 1974; 24: 271-276.
2. Nioka S, Smith A, Mayevsky A, et al.: Age dependemce of steady state mitochondrial oxidative metabolism in the in vivo hypoxic dog brain. Neurol Res 1991; 13: 25-32.
3. Maulik D, Zanelli S, Numagami Y, et al.: Oxygen free radical generation during in-utero hypoxia in the fetal guinea pig brain: the effects of maturity and magnesium sulfate administration. Brain Res 1999; 817: 117-122.
4. Rudolph AM: Distribution and regulation of blood flow in the fetus and neonate lamb. Circ Res 1985; 57: 811-821.
5. Chao CR, Hohimer AR, Bissonnette JM: Fetal cerebral Blood flow and metabolism during oligemia and eary postoligemic reperfusion. J Cereb Blood Flow Metab 1991; 11: 416-423.
6. Siesjo BK, Siesjo P: Mechanisms of secondary brain injury. Eur J Anaesthesiol 1996; 13: 247-268.
7. Ginsberg M, Mela L, Wrobel-Kuhl K, Reivich M: Mitochondrial metabolism following bilateral cerebral ischemia in the gerbil. Ann Neurol 1977; 1: 519-527.
8. Kuroda S, Katsura K, Hillered L, Bates TE, Siesjo BK: Delayed treatment with α-phenyl-N-tert-Butyl-nitrone (PBN) atttenuates secondary mitochondrial dysfunction after transient focal ischemia in the rat. Neurobiol Dis 1996; 3: 149-157.
9. Nakai A, Kuroda S, Kristian T, Siesjo BK: The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction following transient focal cerebral ischemia in the rat. Neurobiol Dis 1997; 4: 288-300.
10. Digiacomo JE, Pane C, Gwiazdowski S, Mishra OP, Delivoria-Papadopoulos M: Effect of graded hypoxia on brain cell membrane injury in newborn piglet. Biol Neonate 1992; 61: 25-32.
11. Nakai A, Asakura H, Taniuchi Y, et al.: Effect of a-phenyl-N-tert-butyl nitrone (PBN) on fetal cerebral energy metabolism during intrauterine ischemia and reperfusion in rats. Pediatr Res 2000; 47: 451-456.
12. Bernardi P, Basso E, Colonna R, et al.: Perspectives on the mitochondrial permeability transition. Biochim Biophys Acta 1998; 1365: 200-206.
13. Rehncrona S, Mela L, Siesjo B: Recovery of brain mitochondrial function in the rat after complete and incomplete cerebral ischemia. Stroke 1979; 10: 437-446.
14. Hillered L, Siesjo BK. Arfors K: Mitochondrial response to transient forebrain ischemia and recirculation in rat. J Cereb Blood Flow Metab 1984; 4: 438-446.
15. Allen K, Almeida A, Bates T, Clark J: Changes of respiratory chain activity in mitochondrial and synaptosomal fractions isolated from the gerbil brain after graded ischaemia. J Neurochem 1995; 64: 2222-2229.
16. Almeida A, Allen KL, Bates TE, Clark JB: Effect of reperfusion following cerebral ischaemia on the activity of the mitochondrial respiratory chain in the gerbil brain. J Neurochem 1995; 65: 1698-1703.
17. Sims NR, Pulsinelli WA: Altered mitochondrial respiration in selectively vulnerable brain subregion following transient forebrain ischemia in the rat. J Neurochem 1987; 49: 1367-1374.
18. Kuroda S, Siesjo BK: Reperfusion damage following focal ischemia: pathophsiology and therapeutic windows. Clin Neurosci 1997; 4: 199-212.
19. Crompton M, Ellinger H, Costi A: Inhibition by cyclosporin A of a Ca2+ dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J 1988; 255: 357-360.
20. Duchen MR, Mcguinness O, Brown LA, Crompton M: On the ivolvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovascular Research 1993; 194: 1790-1794.
21. Richter C: Pro-oxidants and mitochondrial Ca2+: their relationship to apoptosis and oncogenesis. FEBS 1993; 325: 104-107.
22. Bernardi P, Broekemeier KM, Pfeiffer DR: Recent progress on regulation of the mitochondrial permeability transition pore: a cyclosporin-sensitive pore in the inner mitochondrial membrane. J Bioenerg Biomemb 1994; 26: 509-517.
23. Gunter KK, Gunter TE: Transport of calcium by mitochondria. J Bioenerge Biomembrane 1994; 26: 471-485.
24. Zamzami N, Susin SA: Mitochondrial control of nuclear apoptosis. J Exp Med 1996; 183: 1533-1544.
25. Hirsch T, Marzo I, Kroemer G: Role of the mitochondrial permeability transition pore in apoptosis. Biosci Rep 1997; 17: 67-76.
26. Green DR, Reed JC: Mitochondria and apoptosis. Science 1998; 28: 1309-1312.
27. Friberg H, Connern C, Halestrap AP, Wieloch T: Differences in the activation of the mitochondrial permeability transition among brain regions in the rat correlate with selective vulnerability. J Neurochem 1999; 72: 2488-2497.
28. Crompton M, Andreeva L: On the involvement of a mitochondrial pore in reperfusion injury. Basic Res Cardiol 1993; 88: 513-523.
29. Broekemeier KM, Dempsey ME, Pfeiffer DR: Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem 1989; 264: 7826-7830.
30. Halestrap AP, Davidson AM: Inhibition of Ca2+-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem J 1990; 268: 153-160.
31. Connern CP, Halestrap AP: Purification and N-terminal sequencing of peptidyl-prolyl cis-trans-isomerase from rat liver mitochondrial matrix reveals the existence of a distinct mitochondrial cyclophilin. Biochem J 1992; 284: 381-385.
32. Tranveer A, Virji S, Totty NF, et al.: Involvement of cyclophilin D in the activation of a mitochondrial pore by Ca2+ and oxidant stress. Eur J Biochem 1996; 238: 469-471.
33. Uchino H, Elmer E, Uchino K, Siesjo BK: Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischaemia in the rat. Acta Physiol Scand 1995; 155: 469-471.
34. Butcher SP, Henshall DC, Teramura Y, Iwasaki K, Sharkey J: Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. J Neurosci 1997; 15: 6939-6946.
35. Yoshimoto T, Siesjo BK: Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia. Brain Res 1999; 839: 283-291.
36. Nakai A, Taniuchi Y, Asakura H, et al.: Secondary mitochondrial dysfunction after transient intrauterine ischemia in the fetal brain. J Obstet Gynecol Res 2000; 26: 383-387.
37. Nakai A, Shibazaki Y, Taniuchi Y, Koshino T, Yokoyama K: Maternal treatment with NMDA receptor antagonist (MK-801) attenuates secondary mitochondrial dysfunction after transient intrauterine ischemia in neonatal rat brain. J Anesthesia 2001; 15: 217-222.
38. Azzopardi D, Wyatt JS, Cady EB, et al.: Prognosis of newborn infants with hypoxic-ischemic brain injury assessed by phosphorus magnetic resonance spectroscopy. Pediatr Res 1989; 25: 445-451.
39. Yager JY, Brucklacher RM, Vannucci RC: Cerebral energy metabolism during hypoxia-ischemia and early recovery in immature rats. Am J Physiol 1992; 262: H672-H677.
40. Lorek A, Takei Y, Cady EB, et al.: Delayed (secondary) cerebral energy failure after acute hypoxia-ischemia in newborn piglet: continuous 48-hour studies by phosphorus magnetic resonance spectroscopy. Pediatr Res 1994; 36: 699-706.
41. Gilland E, Puka-Sundvall M, Hillered L, Hagberg H: Mitochondrial function and energy metabolism after hypoxia-ischemia in the immature rat brain: involvement of NMDA-receptor. J Cereb Blood Flow Metab 1998; 18: 297-304.
42. Roth SC, Edwards AD, Cady EB, et al.: Relation between cerebral oxidative metabolism following birth asphyxia, and neurodevelopmetal outcome and brain growth at one year. Dev Med Child Neurol 1992; 34: 285-295.
43. Vannucci RC, Lyons DT, Vasta F: Regional cerebral blood flow during hypoxia-ischemia in immature rats. Stroke 1988; 19: 245-250.
44. Ogata ES, Bussey M, Finley S: Altered gas exchange, limited glucose and branched chain amino acids, and hypoinsulinemia retard fetal growth in the rat. Metabolism 1989; 35: 970-977.
45. Yavin E, Inserte-Igual J, Gil S: Ischemia-triggered translocation and inactivation of protein kinase C isoforms in the fetal brain. J Neurochem 1995; 65: 2594-2602.
46. Ishimoto H, Natori M, Tanaka M, et al.: Role of oxygen-derived free radicals in fetal growth retardation induced by ischemia-reperfusion in rats. Am J Physiol 1997; 272: 701-705.
47. Tanaka M, Natori M, Ishimoto H, et al.: Experimental growth retardation produced by transient period of uteroplacental ischemia in pregnant Sprague-Dawley rats. Am J Obstet Gynecol 1994; 171: 1231-1234.
48. Folbergrova J, Macmillan V, Siesjo BK: The effect of moderate and marked hypercapnia upon the energy state and upon the cytoplasmic NADH/NAD+ ratio of the rat brain. J Neurochem 1972; 19: 2497-2505.
49. Lowry OH, Passonneau JV: A flexible system of enzymatic analysis, 1972; Academic Press, New York.
50. Rossem K, Vermarien H, Bourgain R: Construction, calibration and evaluation of PO2 electrodes for chronical implantation in the rabbit brain cortexOxygen Transport to tissue 13, 1992; Plenum Press, New York.
51. Sims N, Blass J: Expression of classical mitochondrial respiratory responses in homogenates of rat forebrain. J Neurochem 1986; 47: 496-505.
52. Lowry O, Rosebrough N, Farr A, Randall R: Protein measurement with folin phenol reagent. J Biol Chem 1951; 193: 265-275.
53. Rosenthal RE, Hamud F, Fiskum G, Varghese PJ, Sharpe S: Cerebral ischemia and reperfusion of brain mitochondrial injury by lidoflazine. J Cereb Blood Flow Metab 1987; 7: 752-758.
54. Kristian T, Gertsch J, Bates TE, Siesjo BK: Characteristics of the calcium-triggered mitochondrial permeability transition in nonsynaptic brain mitochondria: effect of cyclosporin A and ubiquinone 0. J Neurochem 2000; 74: 1999-2009.
55. Kobayashi T: The role of mitochondrial permeability transition in brain ischemia. Hokkaido J Med Sci 2000; 75: 243-252.
56. Auer R, Kalimo H, Olsson Y, Wieloch T: The dentate gyrus in hypoglycemia: Pathology implicating excitotoxin-mediated neuronal necrosis. Acta Neuropathol 1985; 67: 279-288.
57. Friberg H, Ferrand-Drake M, Bengtsson F, Halestrap AP, Wieloch T: Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J Neurosci 1998; 18: 5151-5159.
58. Kunievsky B, Pretsky A, Yavin E: Transient rise of glucose uptake in the fetal rat brain after brief episodes of intrauterine ischemia. Dev Neurosci 1994; 16: 313-320.
59. O'shaughnessy CT, Lythgoe DJ, Butcher SP, et al.: Effect of hypoxia on fetal rat brain metabolism studied in utero by 31P-NMR spectroscopy. Brain Res 1992; 551: 334-337.
60. Berger R, Jensen A, Krieglstein J, Steigelmann J-P: Cerebral energy metabolism in fetal guinea pigs during moderate maternal hypoxemia at 0.75 of gestation. J Dev Physiol 1993; 19: 193-196.
61. Nordstrom C-H, Siesjo BK: Influence of phenobarbital on changes in the metabolites of the energy reserve of the cerebral cortex following complete ischemia. Acta Physiol Scand 1978; 104: 271-280.
62. Onodera H, Iijima K, Kogure M: Mononucleotide metabolism in the rat brain after transient ischemia. J Neurochem 1986; 46: 1704-1710.
63. Siesjo BK, Nilsson L: The influence of arterial hypoxemia upon labile phosphates and upon extracellular and intracellular lactate and pyruvate concentrations in the rat brain. Scand J Clin Lab Invest 1971; 27: 83-96.
64. Siesjo BK: Brain energy metabolism, 1978; Wiley and Sons, Tronto.
65. Beck T, Krieglstein J: Cerebral circulation, metabolism, and blood-brain barrier of rats in hypocapnic hypoxia. Am J Physiol 1987; 252: H504-H512.
66. Berger R, Gjedde A, Heck J, et al.: Application of the Sokoloff method to calculate cerebral glucose consumption in fetal guinea pigs. J Cereb Blood Flow Metab 1991; 11: S869.
67. Welsh FA, Marcy VR, Sims RE: NADH fluorescence and regional energy metabolites during focal ischemia and reperfusion of rat brain. J Cereb Blood Flow Metab 1991; 11: 459-465.
68. Folbergrova J, Zhao Q, Katsura K, Siesjo BK: N-tert-a-phenylnitrone improves recovery of brain energy state in rats following transient focal ischemia. Proc Natl Acad Sci USA 1995; 92: 5057-5061.
69. Haan H, Von Reempts J, Vles J, Haan J, Hasaart T: Effect of asphyxia on the fetal lamb brain. Am J Obstet Gynecol 1993; 169: 1493-1501.
70. Nagasawa H, Kogure K: Correlation betweeen cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke 1989; 20: 1037-1043.
71. Matsuo Y, Kihara T, Ikeda M, et al.: Role of Neutrophils in radical production during ischemia and reperfusion of the rat brain: effect of neutrophil depletion extracellular ascorbyl radical formation. J Cereb Blood Flow Metabo 1995; 15: 941-947.
72. Kuroiwa T, Shibutani M, Okeda R: Nonhyperemic blood flow restoration and brain edema in experimental focal cerebral ischemia. J Neurosurg 1989; 70: 73-80.
73. Tsuchidate R, He Q-P, Smith M-L, Siesjo BK: Regional cerebral blood flow during and following 2 hours of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 1997; 17: 1066-1073.
74. Floyd RA, Carney JM: Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann Nuerol 1992; 32: S22-S27.
75. Del Zoppo GJ, Schmid-Schobein GW, Mori E, Copeland BR, Chang CM: Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 1991; 22: 1276-1283.
76. Nakai A, Taniuchi Y, Asakura H, et al.: Developmental changes in tolerance to transient intrauterine ischemia in rat cerebral mitochondria. Am J Obstet Gynecol 2001; 184: 731-735.
77. Kristian T, Gido G, Kuroda S, Schutz A, Siesjo BK: Calcium metabolism of focal and penumbral tissue in the rats subjected to transient middle cerebral artery occlusion. Exp Brain Res 1998; 120: 503-509.
78. Takeuchi Y, Morii H, Tamura M, Hayaishi O, Watanabe Y: A possible mechanism of mitochondrial dysfunction during cerebral ischemia: inhibition of mitochondrial respiration activity by arachidonic acid. Arch Biochem Biophys 1991; 289: 33-38.
79. Beckman J: The double-edge role of nitric oxide in brain function and superoxide-mediated injury. J Dev Physiol 1991; 15: 53-59.
80. Asakura H, Nakai A, Yokota A, et al.: Continuous observation of nitric oxide production in the fetal rat brain during uteroplacental ischemia. Fetal Diagn Ther 1999; 14: 354-359.
81. Nakai A, Shibazaki Y, Taniuchi Y, et al.: Role of mitochondrial permeability transition in fetal brain damage. Pediatr Neurol 2004; 30: 247-253.
82. Liu X, Kim CN, Yang J, Jemmerson R, Wang X: Induction of apoptotic program in cell free extracts: requirement for dATP and cytochrome C. Cell 1996; 86: 147-157.
83. Wyllie AH, Kerr JFR, Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251-306.
84. Kerr JFR, Gobe GC, Winterford CM, Harmin BV: Anatomical methods in cell death. Meth Cell Biol 1995; 46: 1-27.
85. Gogvadze V: Cyclosporin A protects mitochondria in an in vitro model of hypoxia/reperfusion injury. FEBS Lett 1993; 333: 334-338.
86. Begley DJ, Squires LK, Zlokovic BV, et al.: Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A. J Neurochem 1990; 55: 1222-1230.
87. Shirai A, Naito M, Tatsuta T, et al.: Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P-glycoprotein. Biochim Biophys Acta 1994; 1222: 400-404.
88. Bernareggi A, Rowland M: Physiologic modeling of cyclosporin kinetics in rat and man. J Pharmacokinet Biopharm 1991; 19: 21-50.